Unique challenges in ophthalmic drug discovery

被引：0
|
作者：
Adams, Christopher [1 ]
机构：
[1] Novartis Inst BioMed Res Inc, Global Discovery Chem, Cambridge, MA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
266
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Meeting the unique challenges of drug discovery for neurodegenerative diseases
    Diana W Shineman
    Howard M Fillit
    BMC Neurology, 9 (Suppl 1)
  • [2] Ophthalmic drug discovery
    Clark, AF
    Yorio, T
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (06) : 448 - 459
  • [3] Ophthalmic drug discovery
    Abbot F. Clark
    Thomas Yorio
    Nature Reviews Drug Discovery, 2003, 2 : 448 - 459
  • [4] hiPSC-RPE cells for ophthalmic drug discovery: challenges and opportunities
    Ghosh, Anita K.
    Vergun, Olga
    Hakkarainen, Jenni J.
    Kaja, Simon
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (08) : A94 - A94
  • [5] Meeting the unique challenges of drug discovery for neurodegenerative diseases Introduction
    Shineman, Diana W.
    Fillit, Howard M.
    BMC NEUROLOGY, 2009, 9
  • [6] Ophthalmic Drug Discovery and Development
    Gukasyan, Hovhannes J.
    Hailu, Shumet
    Karami, Thomas K.
    PHARMACEUTICAL RESEARCH, 2019, 36 (05)
  • [7] Ophthalmic Drug Discovery and Development
    Hovhannes J. Gukasyan
    Shumet Hailu
    Thomas K. Karami
    Pharmaceutical Research, 2019, 36
  • [8] Radiochemistry: A Useful Tool in the Ophthalmic Drug Discovery
    Pulagam, Krishna R.
    Gomez-Vallejo, Vanessa
    Llop, Jordi
    Rejc, Luka
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (04) : 501 - 522
  • [9] Challenges of antibacterial drug discovery
    Reck, Folkert
    Jansen, Johanna M.
    Moser, Heinz E.
    ARKIVOC, 2019, : 227 - 244
  • [10] Challenges of allosterism in drug discovery
    Christopoulos, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 28 - 28
12345